| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2007 | US20070190139 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/16/2007 | US20070190138 Stabilized atorvastatin |
| 08/16/2007 | US20070190136 Process for producing fenofibrate tablets |
| 08/16/2007 | US20070190135 Phosphate-binding polymer and tablets using the same |
| 08/16/2007 | US20070190134 Compositions containing nicorandil, preparation method and use |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190130 Protein hydrolysate excipients |
| 08/16/2007 | US20070190129 Sustained release dosage forms of ziprasidone |
| 08/16/2007 | US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors) |
| 08/16/2007 | US20070190126 Method for treating generalized and focal peripheral neuropathies |
| 08/16/2007 | US20070190121 Non-Absorbent Articles Containing Additives for Inhibiting the Production of TSST-1 |
| 08/16/2007 | US20070190120 Administration of non-oral androgenic steroids to women |
| 08/16/2007 | US20070190117 Buccal formulations of galanthamine and uses thereof |
| 08/16/2007 | US20070190115 Feed additive for laying hen and feed containing the same |
| 08/16/2007 | US20070190114 Antioxidant health lozenges |
| 08/16/2007 | US20070190113 Agent for inhibiting postprandial increase in blood neutral fat level and foods containing the same |
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/16/2007 | US20070190109 biodegradable filament having arranged thereon pressed form bodies consisting of at least one member of group of antibiotic salts such as gentamicin myristate, tobramycin palmitate; for treatment of chronic osteomyelitis |
| 08/16/2007 | US20070190107 Cell selective implant surface with controlled release of bioactive agents |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190103 Implantable medical device with surface-eroding polyester drug delivery coating |
| 08/16/2007 | US20070190091 Perfuming or flavouring microcapsules comprising an explosion suppressant |
| 08/16/2007 | US20070190085 Stable pharmaceutical compositions, processes for making the same and methods of their use |
| 08/16/2007 | US20070190081 Aqueous suspension for nasal drops |
| 08/16/2007 | US20070190079 Methods for the selective modulation of ppar |
| 08/16/2007 | US20070190071 9-Substituted 8-oxoadenine compound |
| 08/16/2007 | US20070190070 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system |
| 08/16/2007 | US20070190067 Cationic Steroid Antimicrobial Compositions and Methods of Use |
| 08/16/2007 | US20070190066 Cationic Steroid Antimicrobial Compositions and Methods of Use |
| 08/16/2007 | US20070190064 Enteral composition for the prevention and/or treatment of sepis |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 08/16/2007 | US20070190043 decreasing or inhabiting hyperproliferation of keratinocytes and/or T-cells ; cream; use treating psoriasis or atopic dermatitis for example |
| 08/16/2007 | US20070190042 Composition for collecting and preserving placental stem cells and methods of using the composition |
| 08/16/2007 | US20070190041 Novel benzothiazepine and bensothiepine compounds |
| 08/16/2007 | US20070190033 treatment of a bacterial infection characterized by biofilm formation; for Pseudomonas aeruginosa infections such as those in canine ears |
| 08/16/2007 | US20070190023 Methods and compositions for modulating the mobilization of stem cells |
| 08/16/2007 | US20070190022 Combination methods of treating cancer |
| 08/16/2007 | US20070190021 Poly(diallylamine)-based bile acid sequestrants |
| 08/16/2007 | US20070190020 composition in form of tablet comprising wet granulated salt of (poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane)hydrochloride) and pharmaceutical excipient, wherein salt is granulated using a granulation liquid of an organic solvent or organic solvent/water mixture |
| 08/16/2007 | US20070190019 Compositions and methods for topical administration |
| 08/16/2007 | US20070190018 acetal resin or ketone polymer conjugate; drug covalently attached to polymer via succinamide linkages; the succinamidoester is oriented such that an ester is formed at the carrier side while the carboxyl forms amide bond with an amine-containing drug; glycine link; drug delivery; camptothecin CPT, Taxol |
| 08/16/2007 | US20070190014 Oil - in - polyhydric alcohol type warming base agent |
| 08/16/2007 | US20070189988 Cosmetic and dermatologic oxygen carrier system |
| 08/16/2007 | US20070189985 Use of a compound modifying an interleukin 5, interleukin 6 and/or interleukin 10 secretion for preparing a pharmaceutical composition for rosacea treatment |
| 08/16/2007 | US20070189980 Compositions and methods for treating alopecia |
| 08/16/2007 | US20070189979 Particles |
| 08/16/2007 | US20070189978 Compositions and methods for dermally treating musculoskeletal pain |
| 08/16/2007 | US20070189977 Spray-on formulations and methods for dermal delivery of drugs |
| 08/16/2007 | US20070189968 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 08/16/2007 | DE20221760U1 Verwendung von Seltenerdverbindungen zur Prävention von Nierensteinerkrankung Use of rare earth compounds for the prevention of kidney stone disease |
| 08/16/2007 | DE10234673B4 Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren Hot melt TTS for administering rotigotine and method for its production and use of rotigotine in the production of a TTS in a hot melt procedure |
| 08/16/2007 | DE102006057250A1 Benzochromenderivate Benzochromene derivatives |
| 08/16/2007 | DE102006017600A1 Nucleosidanaloga als Genexpressionsregulatoren bei Viren Nucleoside analogs as regulators of gene expression in viruses |
| 08/16/2007 | DE102006006588A1 Schnell freisetzende Irbesartan-haltige pharmazeutische Zusammensetzung Quick-release irbesartan-containing pharmaceutical composition |
| 08/16/2007 | DE102006006196A1 Nucleosidanaloga als Auslöser der Fehlerkatastrophe bei Viren Nucleoside analogs as the cause of the error catastrophe for viruses |
| 08/16/2007 | DE102006005937A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis |
| 08/16/2007 | DE102006005936A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis |
| 08/16/2007 | DE102006005659A1 Proteasen-Inhibitor zur Wundbehandlung Protease inhibitor for the treatment of wounds |
| 08/16/2007 | DE102005061428A1 Substituierte Cyclohexylmethyl-Derivate Cyclohexylmethyl substituted derivatives |
| 08/16/2007 | CA2651987A1 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 08/16/2007 | CA2642665A1 Anti-cancer pharmaceutical composition |
| 08/16/2007 | CA2642154A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 08/16/2007 | CA2641884A1 Treatment of duchenne muscular dystrophy |
| 08/16/2007 | CA2641883A1 Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant |
| 08/16/2007 | CA2641880A1 Treatment of duchenne muscular dystrophy |
| 08/16/2007 | CA2641854A1 Neutralization of bacterial spores |
| 08/16/2007 | CA2641842A1 Oligosaccharide mixture |
| 08/16/2007 | CA2641827A1 Nebulised antibiotics for inhalation therapy |
| 08/16/2007 | CA2641769A1 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(r)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders |
| 08/16/2007 | CA2641719A1 Process for preparing gemcitabine and associated intermediates |
| 08/16/2007 | CA2641718A1 Bicyclic sphingosine 1-phosphate analogs |
| 08/16/2007 | CA2641685A1 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 08/16/2007 | CA2641683A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | CA2641678A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | CA2641665A1 Modified release formulation |
| 08/16/2007 | CA2641638A1 A direct cellular energy delivery system |
| 08/16/2007 | CA2641632A1 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | CA2641617A1 Bladder cancer treatment and methods involving determination of tumor enzyme level |
| 08/16/2007 | CA2641609A1 11-beta hsd1 inhibitors |
| 08/16/2007 | CA2641579A1 N-hydroxyacrylamide compounds |
| 08/16/2007 | CA2641555A1 Preferential inhibition of presenilin-1 |
| 08/16/2007 | CA2641546A1 Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease |
| 08/16/2007 | CA2641502A1 Metal-containing virucidal compositions and uses |
| 08/16/2007 | CA2641501A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
| 08/16/2007 | CA2641494A1 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/16/2007 | CA2641456A1 Compositions comprising a bisphosphonate and an antifolate |
| 08/16/2007 | CA2641453A1 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 08/16/2007 | CA2641396A1 Process for manufacturing entacapone |
| 08/16/2007 | CA2641393A1 Novel epoprostenol formulation and method of making thereof |
| 08/16/2007 | CA2641392A1 Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders |
| 08/16/2007 | CA2641388A1 Inhibition of hiv infection through chemoprophylaxis |
| 08/16/2007 | CA2641350A1 Aminoindazole derivatives |
| 08/16/2007 | CA2641347A1 Indazole-heteroaryl derivatives |
| 08/16/2007 | CA2641315A1 Osteoporosis associated markers and methods of use thereof |
| 08/16/2007 | CA2641310A1 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/16/2007 | CA2641308A1 Use of phosphatases to treat tumors overexpressing n-cor |
| 08/16/2007 | CA2641307A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | CA2641262A1 Withacnistin compounds for treatment of cancer |
| 08/16/2007 | CA2641198A1 Method for treating peripheral arterial disease with zinc finger proteins |